This trial is testing a new, more precise way of doing radiation therapy that may be more effective and have fewer side effects than the current standard.
- Stage IVB Prostate Cancer
- Prostate Adenocarcinoma
- Stage IIIB Prostate Cancer
- Stage III Prostate Cancer
- Stage IV Prostate Cancer
- Stage IVA Prostate Cancer
2 Primary · 7 Secondary · Reporting Duration: Up to 5 years
Side Effects for
1 Treatment Group
Treatment (SBRT, hormone therapy)
1 of 1
102 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic Body Radiation Therapy · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · Male Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any current vacancies for this research project?
"The study, which you can find more information about on clinicaltrials.gov, is still looking for participants. The post date was June 23rd 2021 and the most recent edit was on July 1st of this year." - Anonymous Online Contributor
Are there any harmful after-effects of Stereotactic Body Radiation Therapy?
"Although Phase 2 trials offer preliminary evidence of a treatment's safety, there is no data supporting its efficacy. For this reason, our team has given Stereotactic Body Radiation Therapy a score of 2." - Anonymous Online Contributor
To date, how many individuals have taken part in this research?
"The listing on clinicaltrials.gov verifies that the research team is still looking for test subjects. The study was put up on 23 June 2021 and edited most recently on 1 July 2022; they are seeking 102 individuals total at a single site." - Anonymous Online Contributor